General Information of Drug (ID: DMJRQDG)

Drug Name
AG-SPT201 Drug Info
Synonyms SPT201; S-pantoprazole sodium trihydrate (ulcer), Ahn-Gook; (S)-pantoprazole sodium trihydrate
Indication
Disease Entry ICD 11 Status REF
Ulcerative colitis DD71 Phase 3 [1]
Cross-matching ID
TTD Drug ID
DMJRQDG

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Approved Drug(s)
Clinical Trial Drug(s)
Preclinical Drug(s)
Investigative Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Dexlansoprazole DM1DBV5 Erosive esophagitis DA25.0 Approved [3]
Rabeprazole DMMZXIW Bacterial infection 1A00-1C4Z Approved [4]
API-023 DM6P93J Gastroesophageal reflux disease DA22.Z Phase 1 [5]
Saliphenylhalamide DMLMRGH Solid tumour/cancer 2A00-2F9Z Preclinical [5]
PA-10040 DMELTM2 Cardiovascular disease BA00-BE2Z Investigative [5]
CA-50040 DMCLN6M Colorectal cancer 2B91.Z Investigative [5]
ARH-1029 DM8NETP Helicobacter infection DA42-DA63 Investigative [5]
OPC-22575 DMO4WH9 Ulcerative colitis DD71 Investigative [5]
CDRI-85/92 DMQDA5W Stomach ulcer DA60.Z Investigative [5]
⏷ Show the Full List of 9 Drug(s)

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Gastric H(+)/K(+) ATPase alpha (ATP4A) TTF1QVM ATP4A_HUMAN Modulator [2]

References

1 ClinicalTrials.gov (NCT01400945) Efficacy Study of AGSPT201 Tablet to Treat Gastroesophageal Reflux Disease. U.S. National Institutes of Health.
2 Effects of pantoprazole, a novel H+/K+-ATPase inhibitor, on duodenal ulcerogenic and healing responses in rats: a comparative study with omeprazole and lansoprazole. J Gastroenterol Hepatol. 1999 Mar;14(3):251-7.
3 Clinical pipeline report, company report or official report of Takeda (2009).
4 Review article: rabeprazole's tolerability profile in clinical trials. Aliment Pharmacol Ther. 1999 Oct;13 Suppl 5:17-23.
5 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 849).